A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)

DUI

D014196 MeSH Browser

CUI

M0021855

CAS

1,2,4-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-

Previous indexing

Piperazines (1971-1974); Pyridines (1971-1974); Triazoles (1971-1974)

History note

86(75); was see under PIPERAZINES 1975-85

Public note

86; was see under PIPERAZINES 1975-85